Current Report Filing (8-k)
21 January 2021 - 5:10AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 20, 2021 (January 14, 2021)
FUSE MEDICAL, INC.
(Exact name of Registrant as Specified in Its Charter)
Delaware
|
000-10093
|
59-1224913
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission File Number)
|
(IRS Employer
Identification No.)
|
|
|
|
1565 North Central Expressway
Suite 220 Richardson, Texas
|
|
75080
|
(Address of Principal Executive Offices)
|
|
(Zip Code)
|
Registrant’s Telephone Number, Including Area Code: (469) 862-3030
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
|
|
Trading
Symbol(s)
|
|
Name of each exchange on which registered
|
Common Stock
|
|
FZMD
|
|
OTCPink
|
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 Other Events
(a) On January 14, 2021, Fuse Medical, Inc. (the “Company”) issued a press release, attached hereto as Exhibit 99.1 announcing that the Company has entered into a marketing agreement with CarePICS Telehealth.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
|
|
Fuse Medical, Inc.
|
|
|
|
|
Date: January 20, 2021
|
|
By:
|
/s/ William E. McLaughlin, III
|
|
|
|
William E. McLaughlin, III
|
|
|
|
Senior Vice President
Chief Financial Officer and Director
|
2
Fuse Medical (PK) (USOTC:FZMD)
Historical Stock Chart
From Aug 2024 to Sep 2024
Fuse Medical (PK) (USOTC:FZMD)
Historical Stock Chart
From Sep 2023 to Sep 2024